Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 228 | 0 | 0 | 0 | 0 |
| Gross Profit | 228 | N/A | N/A | N/A | N/A |
| Operating Expenses | 2,631 | 2,284 | 9,035 | 895 | 966 |
| Operating Income | -2,403 | -2,284 | -9,035 | -895 | -966 |
| Other Income | 30 | 59 | 57 | 22 | 8 |
| Pre-tax Income | -2,374 | -2,225 | -8,978 | -874 | -958 |
| Net Income Continuous | -2,374 | -2,225 | -8,978 | -874 | -958 |
| Net Income | $-2,374 | $-2,225 | $-8,978 | $-874 | $-958 |
| EPS Basic Total Ops | -4.46 | -4.18 | 213.91 | -21.73 | -81.21 |
| EPS Basic Continuous Ops | -4.46 | -4.18 | 213.96 | -21.77 | -81.21 |
| EPS Diluted Total Ops | -4.46 | -4.18 | 213.91 | -21.73 | -81.21 |
| EPS Diluted Continuous Ops | -4.46 | -4.18 | 213.96 | -21.77 | -81.21 |
| EPS Diluted Before Non-Recurring Items | N/A | -4.18 | N/A | -21.73 | -80.99 |
| EBITDA(a) | $-2,390 | $-2,278 | $-9,031 | $-894 | $-965 |